Wu et al.’s [32] research elucidated a pivotal role for the IQGAP2 gene in inhibiting the epithelial–mesenchymal transition (EMT) process in breast cancer through modulation of the Wnt/β-catenin signaling pathway [22], reinforcing its status as a breast cancer suppressor [23]. This evidence concerns the gene IQGAP2 and breast carcinoma.